BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1363515)

  • 1. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S; Gupta S
    Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM; Sinha BK
    Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K; Tsuruo T
    Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
    Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN
    Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M; Madafiglio J; Norris MD; Haber M
    Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
    Marquardt D; Center MS
    Cancer Res; 1992 Jun; 52(11):3157-63. PubMed ID: 1591727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein.
    Marquardt D; McCrone S; Center MS
    Cancer Res; 1990 Mar; 50(5):1426-30. PubMed ID: 1967979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
    Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
    Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
    Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
    Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
    Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
    Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM; Arnold ST; Felsted RL; Sinha BK
    Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of a new multidrug resistant cell line from Friend leukemia cells by short and cyclic exposures to high concentrations of daunorubicin.
    Abbadessa V; Tolomeo M; Luparello M; Perricone R; Cajozzo A; Dusonchet L; Candiloro V; Crosta L; Rausa L
    Haematologica; 1992; 77(2):137-41. PubMed ID: 1356894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.
    Keizer HG; Schuurhuis GJ; Broxterman HJ; Lankelma J; Schoonen WG; van Rijn J; Pinedo HM; Joenje H
    Cancer Res; 1989 Jun; 49(11):2988-93. PubMed ID: 2566376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
    Hamilton G; Cosentini EP; Teleky B; Koperna T; Zacheri J; Riegler M; Feil W; Schiessel R; Wenzi E
    Anticancer Res; 1993; 13(6A):2059-63. PubMed ID: 7905252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
    Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.